| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |